Sundry Photography/iStock Editorial via Getty Images Medtronic ( NYSE: MDT ) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery system in the U.S., targeting a urologic indication. The filings for the Hugo RAS system were submitted in Sundry Photography/iStock Editorial via Getty Images Medtronic ( NYSE: MDT ) confirmed on Saturday the submission of regulatory filings with the FDA to obtain marketing approval for its Hugo robotic-assisted surgery system in the U.S., targeting a urologic indication. The filings for the Hugo RAS system were submitted in
Medtronic is an Ireland-based medical device company that manufactures and supplies therapeutic and diagnostic equipment to treat chronic diseases across the globe.